BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8210639)

  • 1. Detection of residual leukemic cells in adult acute lymphoblastic leukemia by analysis of gene rearrangements and correlation with early relapses.
    Knauf WU; Ho AD; Hoelzer D; Thiel E
    Recent Results Cancer Res; 1993; 131():197-205. PubMed ID: 8210639
    [No Abstract]   [Full Text] [Related]  

  • 2. T-cell receptor gamma and delta junctional gene rearrangements as diagnostic and prognostic biomarker for T-cell acute lymphoblastic leukemia.
    Kode J; Dudhal N; Banavali S; Chiplunkar S
    Leuk Lymphoma; 2006 Apr; 47(4):769-70. PubMed ID: 16886283
    [No Abstract]   [Full Text] [Related]  

  • 3. The incidence of T-cell receptor gene rearrangements in childhood B-lineage acute lymphoblastic leukemia is related to immunophenotype and fusion oncogene expression.
    Meleshko AN; Belevtsev MV; Savitskaja TV; Potapnev MP
    Leuk Res; 2006 Jul; 30(7):795-800. PubMed ID: 16386788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity and specificity of cerebrospinal fluid flow cytometry for the diagnosis of leukemic meningitis in acute lymphoblastic leukemia/lymphoma.
    Mitri Z; Siddiqui MT; El Rassi F; Holden JT; Heffner LT; Langston A; Waller EK; Winton E; McLemore M; Bernal-Mizrachi L; Jaye D; Arellano M; Khoury HJ
    Leuk Lymphoma; 2014 Jul; 55(7):1498-500. PubMed ID: 24134778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.
    Panzer-Grümayer ER; Cazzaniga G; van der Velden VH; del Giudice L; Peham M; Mann G; Eckert C; Schrauder A; Germano G; Harbott J; Basso G; Biondi A; van Dongen JJ; Gadner H; Haas OA
    Clin Cancer Res; 2005 Nov; 11(21):7720-7. PubMed ID: 16278392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of rearrangement of immunoglobulin genes and T cell receptors in determining low numbers of leukemic in children with acute lymphoblastic leukemia].
    Podraza W; Osipowicz E; Ptaszyński K; Lubiński J; Fydryk J
    Pol Tyg Lek; 1991 Dec 2-9; 46(48-49):929-30. PubMed ID: 1845710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Your dilemma, my identity: unusual immunogenetic profiles of pediatric B cell acute lymphoblastic leukemia.
    Gupta A; Goyal M; Nidamanuri KR; Dattatreya PS
    Indian J Pathol Microbiol; 2014; 57(1):78-80. PubMed ID: 24739837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss-of-function but not dominant-negative intragenic
    Kobitzsch B; Gökbuget N; Schwartz S; Reinhardt R; Brüggemann M; Viardot A; Wäsch R; Starck M; Thiel E; Hoelzer D; Burmeister T
    Haematologica; 2017 Oct; 102(10):1739-1747. PubMed ID: 28751559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of minimal residual disease in pediatric acute lymphoblastic leukemia.
    Gaipa G; Basso G; Biondi A; Campana D
    Cytometry B Clin Cytom; 2013; 84(6):359-69. PubMed ID: 23757107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the human homologue of rat NG2 in adult acute lymphoblastic leukemia: close association with MLL rearrangement and a CD10(-)/CD24(-)/CD65s(+)/CD15(+) B-cell phenotype.
    Schwartz S; Rieder H; Schläger B; Burmeister T; Fischer L; Thiel E
    Leukemia; 2003 Aug; 17(8):1589-95. PubMed ID: 12886247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal residual disease detection in Tunisian B-acute lymphoblastic leukemia based on immunoglobulin gene rearrangements.
    Besbes S; Hamadou WS; Boulland ML; Youssef YB; Achour B; Regaieg H; Khelif A; Fest T; Soua Z
    Braz J Med Biol Res; 2017 Jan; 50(1):e5426. PubMed ID: 28099581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols.
    Motlló C; Ribera JM; Morgades M; Granada I; Montesinos P; Brunet S; Bergua J; Tormo M; García-Boyero R; Sarrà J; Del Potro E; Grande C; Barba P; Bernal T; Amigo ML; Grau J; Cervera J; Feliu E;
    Leuk Lymphoma; 2017 Jan; 58(1):145-152. PubMed ID: 27122129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual profiles of pediatric acute lymphoblastic leukemia with MLL gene rearrangement.
    Kubicka M; Soszynska K; Mucha B; Rafinska B; Kolodziej B; Haus O; Styczynski J
    Leuk Lymphoma; 2007 Oct; 48(10):2083-6. PubMed ID: 17917979
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.
    Cavé H; van der Werff ten Bosch J; Suciu S; Guidal C; Waterkeyn C; Otten J; Bakkus M; Thielemans K; Grandchamp B; Vilmer E
    N Engl J Med; 1998 Aug; 339(9):591-8. PubMed ID: 9718378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A competitive PCR-based method using TCRD, TCRG and IGH rearrangements for rapid detection of patients with high levels of minimal residual disease in acute lymphoblastic leukemia.
    Guidal C; Vilmer E; Grandchamp B; Cavé H
    Leukemia; 2002 Apr; 16(4):762-4. PubMed ID: 11960365
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunophenotypic and immunogenotypic detection of minimal residual disease in acute lymphoblastic leukemia.
    van Dongen JJ; Breit TM; Adriaansen HJ; Beishuizen A; Hooijkaas H
    Recent Results Cancer Res; 1993; 131():157-84. PubMed ID: 8210636
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of clonal evolution at Ig/TCR loci in acute lymphoblastic leukaemia by single-strand conformation polymorphism studies and highly resolutive PCR derived methods: implication for a general strategy of minimal residual disease detection.
    Baruchel A; Cayuela JM; MacIntyre E; Berger R; Sigaux F
    Br J Haematol; 1995 May; 90(1):85-93. PubMed ID: 7786801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of detection of monoclonality in remission marrow in acute lymphoblastic leukemia in childhood. Australian and New Zealand Children's Cancer Study Group.
    Brisco MJ; Condon J; Hughes E; Neoh SH; Nicholson I; Sykes PJ; Tauro G; Ekert H; Waters K; Toogood I
    Leukemia; 1993 Oct; 7(10):1514-20. PubMed ID: 8412313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of residual disease in childhood acute lymphoblastic leukemia.
    Machida U; Kami M; Hirai H
    N Engl J Med; 1999 Jan; 340(2):153-4. PubMed ID: 9917221
    [No Abstract]   [Full Text] [Related]  

  • 20. T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis.
    van der Velden VH; Wijkhuijs JM; Jacobs DC; van Wering ER; van Dongen JJ
    Leukemia; 2002 Jul; 16(7):1372-80. PubMed ID: 12094263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.